Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julius Wilder

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Clinical Liver Disease|April 18, 2019
FibroscanKeyur Patel, Julius Wilder
Medical Devices (Auckland, N.Z.)|May 17, 2014
The clinical utility of FibroScan(®) as a noninvasive diagnostic test for liver diseaseJulius Wilder, Keyur Patel
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 6, 2021
Health Equity and Telemedicine in Gastroenterology and HepatologyKara Wegermann, Yuval Patel, Julius Wilder
Nature Reviews. Gastroenterology & Hepatology|November 1, 2024
Health disparities in cirrhosis care and liver transplantationDavid Goldberg, Julius Wilder, Norah Terrault
JAMA|April 17, 2019
Evaluation for Fibrosis After Cure of Hepatitis C-ReplyJulius Wilder, Steve S Choi, Cynthia A Moylan
Clinics in Liver Disease|November 20, 2025
Disparities in Alcohol-Related Liver DiseaseLarissa Lushniak, Ashley Jowell, Stephanie Garbarino, et al.
Journal of the National Medical Association|March 2, 2016
A Systematic Review of Race and Ethnicity in Hepatitis C Clinical Trial EnrollmentJulius Wilder, Anirudh Saraswathula, Vic Hasselblad, et al.
JAMA|November 2, 2018
Vibration-Controlled Transient Elastography for Diagnosing Cirrhosis and Staging Hepatic FibrosisJulius Wilder, Steve S Choi, Cynthia A Moylan
Therapeutics and Clinical Risk Management|January 8, 2020
Acute Intermittent Porphyria: Current Perspectives And Case PresentationZachary Spiritos, Shakirat Salvador, Diana Mosquera, et al.
Hepatology (Baltimore, Md.)|November 5, 2020
Addressing Social Determinants of Liver Disease During the COVID-19 Pandemic and Beyond: A Call to ActionAni Kardashian, Julius Wilder, Norah A Terrault, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Clinical Liver Disease|April 18, 2019
FibroscanKeyur Patel, Julius Wilder
Medical Devices (Auckland, N.Z.)|May 17, 2014
The clinical utility of FibroScan(®) as a noninvasive diagnostic test for liver diseaseJulius Wilder, Keyur Patel
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 6, 2021
Health Equity and Telemedicine in Gastroenterology and HepatologyKara Wegermann, Yuval Patel, Julius Wilder
Nature Reviews. Gastroenterology & Hepatology|November 1, 2024
Health disparities in cirrhosis care and liver transplantationDavid Goldberg, Julius Wilder, Norah Terrault
JAMA|April 17, 2019
Evaluation for Fibrosis After Cure of Hepatitis C-ReplyJulius Wilder, Steve S Choi, Cynthia A Moylan
Clinics in Liver Disease|November 20, 2025
Disparities in Alcohol-Related Liver DiseaseLarissa Lushniak, Ashley Jowell, Stephanie Garbarino, et al.
Journal of the National Medical Association|March 2, 2016
A Systematic Review of Race and Ethnicity in Hepatitis C Clinical Trial EnrollmentJulius Wilder, Anirudh Saraswathula, Vic Hasselblad, et al.
JAMA|November 2, 2018
Vibration-Controlled Transient Elastography for Diagnosing Cirrhosis and Staging Hepatic FibrosisJulius Wilder, Steve S Choi, Cynthia A Moylan
Therapeutics and Clinical Risk Management|January 8, 2020
Acute Intermittent Porphyria: Current Perspectives And Case PresentationZachary Spiritos, Shakirat Salvador, Diana Mosquera, et al.
Hepatology (Baltimore, Md.)|November 5, 2020
Addressing Social Determinants of Liver Disease During the COVID-19 Pandemic and Beyond: A Call to ActionAni Kardashian, Julius Wilder, Norah A Terrault, et al.
Pageof 2